Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)
Hereditary transthyretin amyloidosis belongs to a group of diseases with an autosomal dominant type of transmission and a heterogeneous clinical picture, which depends on the type of transthyretin gene mutation. The leptomeningeal form is a rare phenotypic variant of amyloidosis with a predominant i...
| Published in: | Неврология, нейропсихиатрия, психосоматика |
|---|---|
| Main Authors: | E. I. Safiulina, O. E. Zinovieva, N. S. Shcheglova, V. V. Rameev, Z. V. Surnina, E. N. Nikitina, O. A. Vorobieva |
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2022-12-01
|
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1923 |
Similar Items
Hereditary leptomeningeal transthyretin amyloidosis with heterozygous TTR mutation: a case report and literature review
by: Hong-Tao Chen, et al.
Published: (2025-05-01)
by: Hong-Tao Chen, et al.
Published: (2025-05-01)
Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
by: Monika Gawor, et al.
Published: (2022-12-01)
by: Monika Gawor, et al.
Published: (2022-12-01)
Clinical case of hereditary transthyretin amyloidosis
by: N. Spasova, et al.
Published: (2024-12-01)
by: N. Spasova, et al.
Published: (2024-12-01)
Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)
by: A. S. Draganova, et al.
Published: (2019-07-01)
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment
by: Asuman ARGON, et al.
Published: (2024-01-01)
by: Asuman ARGON, et al.
Published: (2024-01-01)
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)
Cardiac Amyloidosis-Challenging Diagnosis and Unclear Clinical Picture
by: Sylwia Kozak, et al.
Published: (2021-05-01)
by: Sylwia Kozak, et al.
Published: (2021-05-01)
A Comparative Study of the Electroneurographic Findings in Amyloidotic Polyneuropathy in Patients with Light-Chain Amyloidosis and Glu54Gln Transthyretin Amyloidosis
by: Mirela Drăghici, et al.
Published: (2024-12-01)
by: Mirela Drăghici, et al.
Published: (2024-12-01)
Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery
by: Joanna Waś, et al.
Published: (2025-07-01)
by: Joanna Waś, et al.
Published: (2025-07-01)
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
by: Xinyue He, et al.
Published: (2022-09-01)
by: Xinyue He, et al.
Published: (2022-09-01)
Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)
by: Alejandra González-Duarte
Published: (2021-01-01)
A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)
by: E. V. Reznik, et al.
Published: (2021-05-01)
Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data
by: Maximilian Leo Müller, et al.
Published: (2024-07-01)
by: Maximilian Leo Müller, et al.
Published: (2024-07-01)
Genetic and clinical features of hereditary transthyretin amyloidosis: a decade of experience at a Japanese referral center
by: Toshiya Nomura, et al.
Published: (2025-09-01)
by: Toshiya Nomura, et al.
Published: (2025-09-01)
Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024-07-01)
by: A. A. Vedernikov, et al.
Published: (2024-07-01)
Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage
by: Junhui Shen, et al.
Published: (2022-09-01)
by: Junhui Shen, et al.
Published: (2022-09-01)
Integrated specialty care for amyloidosis: a scoping review using the Consolidated Framework for Implementation Research
by: Mary O’Sullivan, et al.
Published: (2025-03-01)
by: Mary O’Sullivan, et al.
Published: (2025-03-01)
Experience of Hereditary Amyloidosis with Rare Variant in Ecuador: Case Reports
by: Diana Elizabeth Luzuriaga Carpio, et al.
Published: (2024-10-01)
by: Diana Elizabeth Luzuriaga Carpio, et al.
Published: (2024-10-01)
Characteristics of Patients with Hereditary Transthyretin Amyloid Polyneuropathy and Chronic Idiopathic Axonal Polyneuropathy in Russia: PRIMER Study Results
by: Natalya A. Suponeva, et al.
Published: (2025-01-01)
by: Natalya A. Suponeva, et al.
Published: (2025-01-01)
Establishment of a Comprehensive Cardiac Amyloidosis Center in a Community Hospital Setting
by: Prabin Phuyal, et al.
Published: (2024-02-01)
by: Prabin Phuyal, et al.
Published: (2024-02-01)
Assessing the effectiveness and safety of Patisiran and Vutrisiran in ATTRv amyloidosis with polyneuropathy: a systematic review
by: Mohammad Amin Karimi, et al.
Published: (2024-09-01)
by: Mohammad Amin Karimi, et al.
Published: (2024-09-01)
A clinical case of transthyretin amyloidosis with manifestations of seronegative arthritis
by: V. A. Mareeva, et al.
Published: (2024-02-01)
by: V. A. Mareeva, et al.
Published: (2024-02-01)
Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells
by: Kenta Ouchi, et al.
Published: (2024-01-01)
by: Kenta Ouchi, et al.
Published: (2024-01-01)
Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)
by: T. A. Adyan, et al.
Published: (2020-01-01)
Efficacy and safety of diflunisal therapy in patients with transthyretin cardiac amyloidosis (ATTR-CA): a systematic review and meta-analysis
by: Wilbert Huang, et al.
Published: (2025-03-01)
by: Wilbert Huang, et al.
Published: (2025-03-01)
A rare presentation of pulmonary transthyretin amyloidosis
by: Marc Assaad, et al.
Published: (2025-01-01)
by: Marc Assaad, et al.
Published: (2025-01-01)
NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE
by: A. Ya. Gudkova, et al.
Published: (2018-03-01)
by: A. Ya. Gudkova, et al.
Published: (2018-03-01)
Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report
by: Benjamin Terrier, et al.
Published: (2017-08-01)
by: Benjamin Terrier, et al.
Published: (2017-08-01)
Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP)
by: Fábio Fernandes, et al.
Published: (2024-07-01)
by: Fábio Fernandes, et al.
Published: (2024-07-01)
Unraveling gut microbiome alterations and metabolic signatures in hereditary transthyretin amyloidosis
by: Hanyu Li, et al.
Published: (2025-07-01)
by: Hanyu Li, et al.
Published: (2025-07-01)
Familial Amyloid Polyneuropathy Misdiagnosed as Systemic Sclerosis
by: Marcia Agostinho Pereira, et al.
Published: (2022-01-01)
by: Marcia Agostinho Pereira, et al.
Published: (2022-01-01)
The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement
by: Chafic Karam, et al.
Published: (2024-11-01)
by: Chafic Karam, et al.
Published: (2024-11-01)
Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies
by: Dana Emilia Movila, et al.
Published: (2025-05-01)
by: Dana Emilia Movila, et al.
Published: (2025-05-01)
Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis
by: Perryn Lin Fei Ng, et al.
Published: (2022-07-01)
by: Perryn Lin Fei Ng, et al.
Published: (2022-07-01)
Introducing a revised version of the Kumamoto scale as an easy-to-use clinical tool for monitoring multisystemic changes in hereditary transthyretin amyloidosis
by: Jonas Wixner, et al.
Published: (2025-07-01)
by: Jonas Wixner, et al.
Published: (2025-07-01)
Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)
by: Mariana Gospodinova, et al.
Published: (2020-07-01)
Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01)
by: Falcão de Campos C, et al.
Published: (2023-02-01)
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis
by: Alessia Argirò, et al.
Published: (2025-04-01)
by: Alessia Argirò, et al.
Published: (2025-04-01)
Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)
by: S. S. Nikitin, et al.
Published: (2021-12-01)
Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications
by: Giedre Balciunaite, et al.
Published: (2020-03-01)
by: Giedre Balciunaite, et al.
Published: (2020-03-01)
Similar Items
-
Hereditary leptomeningeal transthyretin amyloidosis with heterozygous TTR mutation: a case report and literature review
by: Hong-Tao Chen, et al.
Published: (2025-05-01) -
Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
by: Monika Gawor, et al.
Published: (2022-12-01) -
Clinical case of hereditary transthyretin amyloidosis
by: N. Spasova, et al.
Published: (2024-12-01) -
Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01) -
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment
by: Asuman ARGON, et al.
Published: (2024-01-01)
